Traffic Roots Audience Pixel
Slide
Slide 2
Slide 3
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES.
UTI DETECTION & ANTIBIOTIC RESISTANCE
POWERED BY NOVEL MULTIPLEXED MOLECULAR DIAGNOSTICS TECHNOLOGY
Introducing PathogenDx D3 Array™-UTI, a fast multiplexed assay for urinary pathogen detection run simultaneously with antibiotic resistance gene markers to support clinicians in administering rapid UTI treatment and management. This multiplexed UTI assay delivers unrivaled clinical insight in a single test, with same-shift results.
GAIN EASE: Test for 26 causative pathogens + 12 Antibiotic Resistance Genes in a single test, with qualitative detection and quantification in the same sample reaction.
CUT WASTE & COST: Utilize only the wells you need per shift without incurring cost on the rest of the plate—optimizing reagents and consumables spend.
STREAMLINE ANALYSIS: Reduce the time and cost of analyzing reams of raw data via PDx’s Augury automated, cloud-based data analysis and management.
ENSURE ACCURACY: Deliver higher confidence of results through triplicate testing of each pathogen and ABR in a single well reaction.
Learn More »
video
play-rounded-outline
PathogenDX CEO Milan Patel and Clinical Advisor, Susan Evans, PhD, explain the D3 novel multiplexed clinical testing platform.
Slide

Identifies both the pathogen causing the infection and the antibiotic resistance gene marker in the same test. Affordable, accurate triplicate results in each reaction well.

Slide 2

Delivers Higher Accuracy with Triplicate Testing per target.
■    Quantitation is based on three measurements across three hypervariable regions
■    Built in positive and negative controls—no extra wells required

Slide 3

Equipment Agnostic for Greater Flexibility. D3 Array™-UTI uses standard lab equipment to ease into your workflow and deliver ROI.

Slide 4

Gain results faster to keep your workflow humming.

Slide 5

Greater throughput vs other UTI panels—48 samples per plate.

ADVANCED DIAGNOSTICS INCREASING YOUR LAB ROI
D3 Array™-UTI allows us to concentrate all pathogen and antibiotic resistance targets in a single well, allowing us to optimize UTI testing efficiencies through lower cost reagents and consumables—all without compromising content of the test. Labs realize up to 30% cost savings.
TRUE AUTOMATED,
CLOUD-BASED DATA ANALYSIS
Unlike current qPCR UTI testing solutions that churn out reams of raw data that requires manual analysis simply to complete your process, D3 Array™-UTI is paired with Augury cloud-based automated analysis that identifies target confirmation, avoiding hours of analog heavy-lifting for bioinformaticians and labor costs for you.
NO MORE WASTED WELLS
Too often other platforms force labs to waste cost on unused wells because their workflow demands using every well of a plate in a single shift regardless of the number of samples. With D3 Array™-UTI, we provide built-in flexibility for labs to run the number of wells for the samples they have without losing economics on the rest of the wells of the plate.
Slide
WHAT D3 ARRAY™-UTI TESTS FOR

bacterial species

Acinetobacter baumannii
Aerococcus urinae
Citrobacter (freundii, koseri)
Enterobacter (aerogenes, cloacae)
Enterococcus (faecalis, faecium)
Escherichia coli
Klebsiella (oxytoca, pneumoniae)
Morganella morganii

Mycoplasma (hominis, genitalium)
Proteus (mirabilis, vulgaris)
Providencia stuartii
Pseudomonas aeruginosa
Serratia marcescens
Staphylococcus (aureus, saprophyti-cus)
Streptococcus agalactiae
Ureaplasma (parvum, urea)

Qualitative and Quantitative Detection in the same reaction

Slide 2
WHAT D3 ARRAY™-UTI TESTS FOR

antibiotic resistance
gene markers

Tetracycline (tetM)
ESBL (blaTEM, blaSHV, blaCTX-M-1)
Trimethoprim (dfrA1)
Methicilin (mecA)
Quinolone (Gyrase A)
Aminoglycoside (aac6-1b-cr)
Ampicillin (blaACT)

Vancomycin (VanA)
Carbapenem (OXA-48)
Colistin (mcr-1)

fungal species

Candida (albicans, glabrata)

Qualitative and Quantitative Detection in the same reaction

previous arrow
next arrow
THE TOP LINE? NEW EFFICIENCES IN UTI TESTING
  • More flexible, faster and lower cost testing than qPCR or NGS technology
  • Equipment agnostic, compatible with routine molecular instrumentation
  • Simultaneous testing for all targets of interest for greater efficiencies
  • Each sample analyzed in triplicate for Quality Assurance
  • No wasted test wells, use only what you need per run
  • 3D cross-linked array architecture enabling rapid probe binding
  • Reporting, easy and simple—cloud-based, tool-enabled
  • Based on our patented D3 (Dynamic Dimensional Detection) technology
FOR RESEARCH USE ONLY.
NOT FOR USE IN DIAGNOSTIC PROCEDURES.
Learn more about D3 Array™-UTI and PathogenDx.